评估血浆β淀粉样蛋白40和β淀粉样蛋白42作为轻度认知障碍患者转化为阿尔茨海默病预测指标的价值。 - Suppr

Suppr

超能文献

Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

作者信息

Kester Maartje I, Verwey Nicolaas A, van Elk Evert J, Scheltens Philip, Blankenstein Marinus A

出版信息

Neurobiol Aging. 2010 Apr;31(4):539-40; author reply 541. doi: 10.1016/j.neurobiolaging.2008.07.024. Epub 2008 Oct 28.

DOI:10.1016/j.neurobiolaging.2008.07.024

PMID:18963255

Abstract

摘要

相似文献

Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.评估血浆β淀粉样蛋白40和β淀粉样蛋白42作为轻度认知障碍患者转化为阿尔茨海默病预测指标的价值。

Neurobiol Aging. 2010 Apr;31(4):539-40; author reply 541. doi: 10.1016/j.neurobiolaging.2008.07.024. Epub 2008 Oct 28.

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.评估血浆 Abeta(40) 和 Abeta(42) 作为轻度认知障碍患者向阿尔茨海默病转化的预测因子。

Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19.

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.利用脑脊液β淀粉样蛋白42/β淀粉样蛋白40比值预测轻度认知障碍患者的阿尔茨海默病

Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19.

Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.阿尔茨海默病、轻度认知障碍和脑淀粉样血管病中的血浆β-淀粉样蛋白与白质病变

Neurology. 2006 Jan 10;66(1):23-9. doi: 10.1212/01.wnl.0000191403.95453.6a.

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.从认知健康到轻度认知障碍和阿尔茨海默病的转变：由血浆β淀粉样蛋白42、内侧颞叶萎缩和同型半胱氨酸进行预测

Neurobiol Aging. 2008 Jan;29(1):1-11. doi: 10.1016/j.neurobiolaging.2006.09.002. Epub 2006 Oct 19.

CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.脑脊液β淀粉样蛋白42、tau蛋白或磷酸化tau蛋白与轻度认知障碍进展的预测

Neurology. 2005 Apr 12;64(7):1294-7. doi: 10.1212/01.WNL.0000156914.16988.56.

Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.血清淀粉样蛋白P成分作为轻度认知障碍和阿尔茨海默病的生物标志物

Dement Geriatr Cogn Disord. 2008;26(6):522-7. doi: 10.1159/000178756. Epub 2008 Dec 2.

No correlation between time-linked plasma and CSF Abeta levels.血浆和脑脊液 Abeta 水平与时间无相关性。

Neurochem Int. 2009 Dec;55(8):820-5. doi: 10.1016/j.neuint.2009.08.006. Epub 2009 Aug 18.

White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Abeta42 levels.在脑脊液β淀粉样蛋白42（CSF Abeta42）水平正常的患者中，白质病变严重程度与认知能力下降有关。

Acta Neurol Scand. 2008 Dec;118(6):373-8. doi: 10.1111/j.1600-0404.2008.01045.x. Epub 2008 May 28.

Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.脑脊液β-淀粉样蛋白1-42和tau蛋白作为轻度认知障碍患者阿尔茨海默病预测指标的价值

Mol Psychiatry. 2004 Jul;9(7):705-10. doi: 10.1038/sj.mp.4001473.

引用本文的文献

Serum amyloid beta 42 levels correlated with metabolic syndrome and its components.血清淀粉样蛋白β 42 水平与代谢综合征及其组分相关。

Front Endocrinol (Lausanne). 2024 Feb 8;15:1278477. doi: 10.3389/fendo.2024.1278477. eCollection 2024.

Amsterdam Dementia Cohort: Performing Research to Optimize Care.阿姆斯特丹痴呆队列研究：实施研究以优化照护。

J Alzheimers Dis. 2018;62(3):1091-1111. doi: 10.3233/JAD-170850.

Risk factors for the progression of mild cognitive impairment to dementia.轻度认知障碍向痴呆进展的危险因素。

Clin Geriatr Med. 2013 Nov;29(4):873-93. doi: 10.1016/j.cger.2013.07.009.

Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2.高血压患者血浆淀粉样蛋白 β 水平的连锁分析提示 Aβ-40 水平与早老素 2 相关。

Hum Genet. 2012 Dec;131(12):1869-76. doi: 10.1007/s00439-012-1210-2. Epub 2012 Aug 8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验